195 related articles for article (PubMed ID: 7207081)
1. Medical costs and the drug industry.
Schwartz H
Med Times; 1981 Mar; 109(3):21s-24s, 28s. PubMed ID: 7207081
[No Abstract] [Full Text] [Related]
2. Medical costs and the drug industry.
Schwartz H
Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744
[No Abstract] [Full Text] [Related]
3. Costs of submitting an IND and obtaining an effective NDA for a new oral drug.
Elvers WB
Pharmacol Ther Dent; 1971 Feb; 1(2):102-10. PubMed ID: 5293558
[No Abstract] [Full Text] [Related]
4. Pharmacoeconomics: determining the value of drug therapy.
Peterson C
Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751
[No Abstract] [Full Text] [Related]
5. The medicolegal aspects of adverse drug reactions.
Bernstein HN; Levine AM
Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801
[No Abstract] [Full Text] [Related]
6. Dr. Goddard and the PMA.
Rev Allergy; 1969 Mar; 23(3):161-3. PubMed ID: 5786222
[No Abstract] [Full Text] [Related]
7. How effective are medicines in containing health-care costs?
Pharm Times; 1982 Aug; 48(8):38-40. PubMed ID: 10257236
[No Abstract] [Full Text] [Related]
8. American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.
Pediatrics; 1970 Nov; 46(5):811-3. PubMed ID: 5536437
[No Abstract] [Full Text] [Related]
9. 'Now it's their turn'.
Silverman M
J Am Pharm Assoc; 1971 Jul; 11(7):374-5 passim. PubMed ID: 5142131
[No Abstract] [Full Text] [Related]
10. Rising costs hold up drug discovery.
Miller HI
Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
[No Abstract] [Full Text] [Related]
11. Therapeutic freedom.
Trout ME
J Leg Med (N Y); 1974; 2(5):40-2. PubMed ID: 4548704
[No Abstract] [Full Text] [Related]
12. On the "costs" of the 1962 drug amendments.
Smith MC; Visconti JA
Inquiry; 1974 Mar; 11(1):61-4. PubMed ID: 4274295
[No Abstract] [Full Text] [Related]
13. Food and Drug Administration. Tempest over polio vaccine.
Anderson C
Nature; 1991 Jun; 351(6327):510. PubMed ID: 2046758
[No Abstract] [Full Text] [Related]
14. Big Pharma's Commedia.
Steele FR
Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
[No Abstract] [Full Text] [Related]
15. Should off-label drug use be off-the-table?
Rivkees SA
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):171-2. PubMed ID: 17396432
[No Abstract] [Full Text] [Related]
16. [The heavily increasing costs of drugs].
Kampmann JP
Ugeskr Laeger; 1989 Apr; 151(14):905-7. PubMed ID: 2711502
[No Abstract] [Full Text] [Related]
17. A prescription for better prescriptions.
Woosley RL
Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
[No Abstract] [Full Text] [Related]
18. Who pays what in drug development.
Love J
Nature; 1999 Jan; 397(6716):202. PubMed ID: 9930689
[No Abstract] [Full Text] [Related]
19. What does R&D really cost?
Huff B
GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
[No Abstract] [Full Text] [Related]
20. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
Schultheis LW; Rappaport BA
Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
